| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.17 | 0.004 |